Clinical Trials Directory

Trials / Terminated

TerminatedNCT02579993

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation Expanded in Vitro on Amniotic Membrane in Patients With Limbal Stem Cell Deficiency.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

In this study the prognostic value of ABCB5 in survival of the limbal stem cell transplantation expanded in vitro on amniotic membrane for corneal surface reconstruction in patients with limbal stem cell deficiency will be analyzed.

Detailed description

There are several diseases that cause the cornea to lose its clarity and directly affects the vision of the individual, therefore, the use of limbal stem cells has been having increasing acceptance in the field of medical therapy. An open clinical study is running with patients with limbal stem cell deficiency, performing a limbal stem cell transplantation expanded in vitro on amniotic membrane and the value of ABCB5 as a prognostic factor in the survival of transplant will be determined. The corneal surface status will be the primary endpoint.

Conditions

Interventions

TypeNameDescription
PROCEDUREPannus and conjunctival dissectionA complete conjunctival peritomy is performed and the fibrovascular pannus and conjunctiva invading the cornea is dissected from the cornea and limbus.
PROCEDUREHuman cultivated limbal stem cell transplantationThe amniotic membrane graft cultured with the human limbal stem cell transplantation is placed in the limbic and corneal surface and fixed with fibrin glue. The amniotic membrane is placed with the stroma in contact with the graft and it is sutured.

Timeline

Start date
2015-03-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2015-10-20
Last updated
2018-03-06

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02579993. Inclusion in this directory is not an endorsement.

ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation (NCT02579993) · Clinical Trials Directory